CHARLOTTESVILLE, Va., Dec. 14, 2022 /PRNewswire/ — BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by...

What is the mission of ZielBio? Our mission is to improve patient lives by discovering cancer’s Achilles heel. We really want to be innovative and figure out what drives cancer...

We chat with Brian Wamhoff, Head of Innovation and COO of HemoShear Therapeutics.

We chat with Thomas Thorpe, founder and CEO of Afton Scientific.

We talk with Martin Chapman, President and CEO of Indoor Biotechnologies.

RIVANNA to invest $260,000 to renovate facility and more than double its workforce.

Industry Veteran Will Lead HST5040 and Future Rare Disease Clinical Program.

Susan Klees, HemoShear vice president of communications, has been appointed by Governor Ralph Northam to the Virginia Rare Disease Council.

Charlottesville based companies Advaray, AgroSpheres, Bonumose, Cerillo, Contraline, and Icarus Medical are among those awarded in inaugural round of Commonwealth Commercialization Fund awards.

Financing boosts Owl Peak Labs’ development of novel early detection solutions for colorectal cancer.

BIO-CAT, Inc., a biotechnology company that specializes in enzymes and other advanced microbial solutions, plans to add at least 30,000 square feet to its fermentation facilities in Zion Crossroads.